With the stock's last traded price at Rs 1,728.30, Sun Pharmaceutical Industries demonstrates strong financial metrics and active corporate actions, contributing to its market performance.

LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...

Sun Pharmaceutical Industries Ltd rose for a third straight session today. The stock is quoting at Rs 1725.7, up 2.56% on the ...

The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...

We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In ...

Calling upon all relevant stakeholders to position local pharmaceutical manufacturing as a ‘thrust industry’ which can reduce ...

Looking for stocks to buy today? Market experts Raja Venkatraman, Trade Brains Portal, and MarketSmith India share their best ...

Join our Computer System Validation Boot Camp to master FDA regulations, including 21 CFR Part 11, and gain hands-on experience in validation projects. Register to secure training materials, live ...

Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).

Shares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for sev ...

LinkedIn’s Cities on the Rise 2025 report spotlights India’s fastest-growing job markets beyond metros. Tier 2 and 3 cities ...

Healthcare and pharma companies like Dr Reddy's Laboratories, Laurus Labs Ltd, Alembic Pharmaceuticals Ltd and Sun Pharma are ...